# Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia

> **NCT03243656** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 20 (actual)

## Conditions studied

- Eltrombopag

## Interventions

- **DRUG:** Eltrombopag

## Key facts

- **NCT ID:** NCT03243656
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-20
- **Primary completion:** 2019-12-29
- **Final completion:** 2020-01-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03243656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03243656, "Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03243656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*